Maintenance fees coming due
5 maintenance fees come due in the 12 months from Nov 15, 2026, the next on Jan 14, 2027. Unpaid by Jul 14, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 9,079,893 | Ureido-Pyrazole Derivatives for Use in the Treatment of Respiratory Syncitial Virus (RSV) Infection In force Fee due Jan 14, 2027 Lapses if unpaid Jul 14, 2027 · High confidence | Respivert Ltd. | In force | Jan 14, 2027 | Jul 14, 2027 | High confidence | |
| US 10,358,445 | Respiratory Formulations and Compounds for Use Therein In force Fee due Jan 23, 2027 Lapses if unpaid Jul 23, 2027 · High confidence | Respivert Ltd. | In force | Jan 23, 2027 | Jul 23, 2027 | High confidence | |
| US 9,108,950 | 1-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- 1- Yl) Ureas as P38 Map Kinase Inhibitors In force Fee due Feb 18, 2027 Lapses if unpaid Aug 18, 2027 · High confidence | Respivert Limited | In force | Feb 18, 2027 | Aug 18, 2027 | High confidence | |
| US 9,242,960 | P38MAP Kinase Inhibitors In force Fee due Jul 26, 2027 Lapses if unpaid Jan 26, 2028 · Medium confidence | Respivert Ltd. | In force | Jul 26, 2027 | Jan 26, 2028 | Medium confidence | |
| US 9,260,410 | P38 Map Kinase Inhibitors In force Fee due Aug 16, 2027 Lapses if unpaid Feb 16, 2028 · Medium confidence | Respivert Ltd. | In force | Aug 16, 2027 | Feb 16, 2028 | Medium confidence |
5 of 5 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.